drugset / Trial / NCT02765555
First in Man Study of Safety, Tolerability and PK Profile of RBP-7000
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety, tolerability and PK profile of a single dose of 60mg RBO-7000 in stable subjects with schizophrenia who are on medication other than risperidone.
Timeline
- Start
- 2010-03
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 60 mg | — |